Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003639466 | SCV004386137 | uncertain significance | Idiopathic generalized epilepsy | 2023-09-12 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with GABRD-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.001%). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 396 of the GABRD protein (p.Val396Leu). |